Photo taken from Paolo Tarantino/X
Feb 27, 2024, 15:23
Paolo Tarantino: Great JSMO24 session on HR+ MBC
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, recently posted on X/Twitter:
“Great JSMO24 session on HR+ MBC, with Matt Goetz covering new endocrine treatments, myself tasked with reviewing the evolving landscape of targeted drugs, Otto Metzger covering new biomarkers, Hope Rugo exploring recent data with ADCs and chairing by Erika Hamilton and Toru Mukohara.”
Source: Paolo Tarantino/X